Cost-effectiveness of rotavirus immunization in Indonesia: Taking breastfeeding patterns into account

Vaccine

Volumn 31, Issue 32, 2013, Pages 3300-3307

  Suwantika, Auliya A ^a,b   Tu, Hong Anh T ^c   Postma, Maarten J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Affordability; Breastfeeding; Cost effectiveness; Rotavirus; Vaccination

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; BREAST FEEDING; CHILD; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; GROSS NATIONAL PRODUCT; HEALTH CARE SYSTEM; HUMAN; IMMUNIZATION; INDONESIA; INFANT; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

BREAST FEEDING; CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; INDONESIA; INFANT; MODELS, ECONOMIC; MONTE CARLO METHOD; QUALITY-ADJUSTED LIFE YEARS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84879463860     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.055     Document Type: Article

References (27)

1. Soenarto Y., Aman A.T., Bakri A., Waluya H., Firmansyah A., Kadim M., et al. Burden of severe rotavirus diarrhea in Indonesia. J Infect Dis 2009, 200(Suppl. 1):S188-S194.
2. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9(5):565-572.
3. PATH. A Comprehensive approach to rotavirus vaccines. Available from the website: 2012 [accessed on 25.04.12]. http://www.path.org/publications/files/VAC_rotavirus_fs.pdf.
4. Weinberg R.J., Tipton G., Klish W.J., Brown M.R. Effect of breast-feeding on morbidity in rotavirus gastroenteritis. Pediatrics 1984, 74(2):250-253.
5. Wobudeya E., Bachou H., Karamagi C.K., Kalyango J.N., Mutebi E., Wamani H., et al. Breastfeeding and the risk of rotavirus diarrhea in hospitalized infants in Uganda: a matched case control study. BMC Pediatrics 2011, 11-17.
6. Newburg D.S., Peterson J.A., Ruiz-Palacios G.M., Matson D.O., Morrow A.L., Shults J., et al. Role of human milk lactadherin in protection against symptomatic rotavirus infection. The Lancet 1998, 351:1160-1164.
7. WHO. Nutrition, exclusive breastfeeding. Available from the website: 2012 [accessed on 25.04.12]. http://www.who.int/nutrition/topics/exclusive_breastfeeding/en/.
8. Wilopo S.A., Kilgore P., Kosen S., Soenarto Y., Aminah S., Cahyono A., et al. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Vaccine 2009, 27S:F67-F74.
9. PATH. Rotavirus investment case. Available from the website: 2012 [accessed on 25.04.12]. http://fr.gavialliance.org/resources/Rotavirus_Investment_Case_Oct06.pdf.
10. Rozenbaum M.H., Mangen M.J., Giaquinto C., Wilschut J.C., Hak E., Postma M.J. Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model. BMC Publ Health 2011, 11:462.
11. Tu H.A.T., Rozenbaum M.H., Coyte P.C., Li S.C., Woerdenbag H.J., Postma M.J. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries. Vaccine 2012, 30:1521-1528.
12. Muangchana C., Riewpaiboon A., Jiamsiri S., Thamapornpilas P., Warinsatian P. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand. Vaccine 2012, 30:2839-2847.
13. Kim S.Y., Goldie S.J., Salomon J.A. Cost-effectiveness of rotavirus vaccination in Vietnam. BMC Publ Health 2009, 9(29):1-12.
14. Postma M.J., Jit M., Rozenbaum M.H., Standaert B., Tu H.A.T., Hutubessy R.C. Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world. BMC Med 2011, 9:84.
15. BPS-Statistics Indonesia, National Family Planning Coordinating Board (NFPCB), Ministry of Health. Indonesia Demographic and Health Survey 2007; [FR218]: 161-181.
16. Feachem R.G., Koblinsky M.A. Interventions for the control of diarrhoeal diseases among young children: promotion of breast-feeding. Bull World Health Org 1984, 62(2):271-291.
17. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroentritis. N Engl J Med 2006, 354(1):1-12.
18. Dennehy P.H., Vesikari T., Matson D.O., Itzler R.F., Dallas M.J., Goveia M.G., et al. Efficacy of the pentavalent rotavirus vaccine Rotateq: between doses of a 3-dose series and with less than 3 doses (incomplete regimen). Hum Vaccines 2011, 7(5):563-568.
19. WHO. Indonesia: WHO and UNICEF estimates of immunization coverage: 2011 revision. Available from the website: 2012 [accessed on 15.05.12]. http://www.who.int/immunization_monitoring/data/idn.pdf.
20. Lerman S.J., Shepard D.S., Cash R.A. Treatment of diarrhea in Indonesian children: what it costs and who pays for it. The Lancet 1985, 21:651-654.
21. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-effectiveness in health and medicine 1996, Oxford University Press, New York.
22. WHO. WHO guide for standardization of economic evaluations of immunization programmes. WHO/IVB/08.14; 2008:58-68.
23. The World Bank. GDP per capita. Available from the website: 2012 [accessed on 30.11.12]. http://data.worldbank.org/indicator/NY.GDP.PCAP.CD.
24. Bilcke J., Beutels P. Reviewing the cost-effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources. Pharmacoeconomics 2009, 27(4):281-297.
25. Shim E., Banks H.T., Castillo-Chavez C. Seasonality of rotavirus infection with its vaccination. Math Subject Class 1991, 92D30-62F25.
26. GAVI. Republic of Indonesia, application for support to immunization services and new and under-used vaccines. 2008:10-11.
27. Biofarma. Biofarma, focus on development of new vaccine. Available from website: 2012 [accessed on 5.5.12]. http://www.biofarma.co.id/index.php/detil/items/589.html.